Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres<sup>®</sup> Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis.

Front Oncol · 2021 · PMC8008112 · PMID 33796448

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Furthermore, CSM-TACE exhibited a trend toward improved progression free survival (hazard ratio (HR): 0.86, 95%CI: 0.67–1.11) and overall survival (HR: 0.79, 95%CI: 0.59–1.07) over cTACE although these differences did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

The pooled results showed a trend toward longer PFS (HR: 0.86, 95% CI: 0.67–1.11) ( Figure 5A ) and OS (HR: 0.79, 95% CI: 0.59–1.07) ( Figure 5B ) with CSM-TACE compared with cTACE, although these differences did not reach statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.